MINT-FUROSEMIDE
MINT-FUROSEMIDE
Approved
DIN Number
02466775
Drug Class
Human
Market Date
Jul 30, 2018
Company
HC
mint pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02466775
AIG Number0101944004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03CA01 FUROSEMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
FUROSEMIDEActive
Strength: 80 MG
Monograph: FUROSEMIDE